N
TWST icon

Natixis’s Twist Bioscience TWST Stock Holding History

Natixis’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-103,688
Closed -$3.29M – 1325
2025
Q4 		$3.29M Buy
+103,688
New +$3.24M 0.01% 538
2022
Q4 		– Sell
-82,060
Closed -$2.89M – 1349
2022
Q3 		$2.89M Buy
+82,060
New +$3.48M 0.01% 520
2022
Q1 		– Sell
-8,864
Closed -$686K – 1333
2021
Q4 		$686K Sell
8,864
-36,362
-80% -$3.73M ﹤0.01% 980
2021
Q3 		$4.84M Buy
+45,226
New +$5.18M 0.02% 547
2021
Q2 		– Sell
-20,766
Closed -$2.57M – 1052
2021
Q1 		$2.57M Sell
20,766
-2,379
-10% -$361K 0.01% 639
2020
Q4 		$3.27M Buy
+23,145
New +$2.57M 0.01% 594

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Natixis's TWST Position: Q1 2026 in Review

Natixis sold out of Twist Bioscience (TWST) in Q1 2026, closing a stake of 103,688 shares — an estimated $3.29M sold.

Natixis first reported a position in TWST in Q4 2020 and held it in 6 quarters. The position peaked at $4.84M in Q3 2021. 281 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Natixis reported no remaining Twist Bioscience position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 103,688 Twist Bioscience shares in Q1 2026, an estimated $3.29M.
  • Natixis first reported a position in Twist Bioscience in Q4 2020 and held it in 6 quarters.
  • Natixis's Twist Bioscience position peaked at $4.84M in Q3 2021.
  • 281 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.